Empowered Patient Podcast

Eric Mayer, CEO of New Day Diagnostics, is tapping into the trend for more user-friendly diagnostics that patients can use to test themselves for making medical decisions. While blood draw facilities and complex testing will always be a component of healthcare, as technology progresses, more at-home testing will become available. To better support patients and providers, New Day is finding less invasive ways to collect biomarker information and using AI and machine learning to refine the interpretation of test results.  Eric explains, "The business model is very straightforward. We design and develop our suite of diagnostic products that cover cancer testing, infectious disease testing, digestive disease, and women's health. We also operate a contract research laboratory and CRO services for other diagnostics developers, whether point-of-care or over-the-counter, who want to bring those products through the FDA. We help with those studies, and we help with the clinical trials. And then, we also deploy diagno